MGNX
Price
$1.21
Change
+$0.02 (+1.68%)
Updated
Jun 30 closing price
Capitalization
76.97M
42 days until earnings call
MRKR
Price
$1.53
Change
+$0.07 (+4.79%)
Updated
Jun 30 closing price
Capitalization
17.31M
Interact to see
Advertisement

MGNX vs MRKR

Header iconMGNX vs MRKR Comparison
Open Charts MGNX vs MRKRBanner chart's image
MacroGenics
Price$1.21
Change+$0.02 (+1.68%)
Volume$716.59K
Capitalization76.97M
Marker Therapeutics
Price$1.53
Change+$0.07 (+4.79%)
Volume$52.51K
Capitalization17.31M
MGNX vs MRKR Comparison Chart in %
Loading...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRKR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MGNX vs. MRKR commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGNX is a Hold and MRKR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (MGNX: $1.21 vs. MRKR: $1.53)
Brand notoriety: MGNX and MRKR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MGNX: 52% vs. MRKR: 41%
Market capitalization -- MGNX: $76.97M vs. MRKR: $17.31M
MGNX [@Biotechnology] is valued at $76.97M. MRKR’s [@Biotechnology] market capitalization is $17.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MGNX’s FA Score shows that 0 FA rating(s) are green whileMRKR’s FA Score has 1 green FA rating(s).

  • MGNX’s FA Score: 0 green, 5 red.
  • MRKR’s FA Score: 1 green, 4 red.
According to our system of comparison, MRKR is a better buy in the long-term than MGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MGNX’s TA Score shows that 3 TA indicator(s) are bullish while MRKR’s TA Score has 5 bullish TA indicator(s).

  • MGNX’s TA Score: 3 bullish, 7 bearish.
  • MRKR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, MRKR is a better buy in the short-term than MGNX.

Price Growth

MGNX (@Biotechnology) experienced а -8.33% price change this week, while MRKR (@Biotechnology) price change was +7.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.71%. For the same industry, the average monthly price growth was +31.92%, and the average quarterly price growth was +6.10%.

Reported Earning Dates

MGNX is expected to report earnings on Aug 12, 2025.

MRKR is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+3.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGNX($77M) has a higher market cap than MRKR($17.3M). MRKR YTD gains are higher at: -50.804 vs. MGNX (-62.769). MRKR has higher annual earnings (EBITDA): -6.13M vs. MGNX (-47.33M). MGNX has more cash in the bank: 154M vs. MRKR (13.7M). MRKR has less debt than MGNX: MRKR (0) vs MGNX (37.5M). MGNX has higher revenues than MRKR: MGNX (152M) vs MRKR (6.59M).
MGNXMRKRMGNX / MRKR
Capitalization77M17.3M445%
EBITDA-47.33M-6.13M772%
Gain YTD-62.769-50.804124%
P/E RatioN/AN/A-
Revenue152M6.59M2,306%
Total Cash154M13.7M1,124%
Total Debt37.5M0-
FUNDAMENTALS RATINGS
MGNX vs MRKR: Fundamental Ratings
MGNX
MRKR
OUTLOOK RATING
1..100
7879
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
21
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
9158
P/E GROWTH RATING
1..100
95100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MRKR's Valuation (21) in the Other Consumer Services industry is somewhat better than the same rating for MGNX (80) in the Biotechnology industry. This means that MRKR’s stock grew somewhat faster than MGNX’s over the last 12 months.

MRKR's Profit vs Risk Rating (100) in the Other Consumer Services industry is in the same range as MGNX (100) in the Biotechnology industry. This means that MRKR’s stock grew similarly to MGNX’s over the last 12 months.

MGNX's SMR Rating (97) in the Biotechnology industry is in the same range as MRKR (98) in the Other Consumer Services industry. This means that MGNX’s stock grew similarly to MRKR’s over the last 12 months.

MRKR's Price Growth Rating (58) in the Other Consumer Services industry is somewhat better than the same rating for MGNX (91) in the Biotechnology industry. This means that MRKR’s stock grew somewhat faster than MGNX’s over the last 12 months.

MGNX's P/E Growth Rating (95) in the Biotechnology industry is in the same range as MRKR (100) in the Other Consumer Services industry. This means that MGNX’s stock grew similarly to MRKR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MGNXMRKR
RSI
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 29 days ago
83%
Bullish Trend 7 days ago
80%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRKR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AYTU2.180.08
+3.81%
Aytu BioPharma
KOD3.730.04
+1.08%
Kodiak Sciences
STE240.221.43
+0.60%
STERIS plc
ALVO9.12-0.02
-0.22%
Alvotech
ETD27.85-0.07
-0.25%
Ethan Allen Interiors

MGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGNX has been loosely correlated with CRBU. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if MGNX jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGNX
1D Price
Change %
MGNX100%
+1.68%
CRBU - MGNX
52%
Loosely correlated
N/A
XNCR - MGNX
50%
Loosely correlated
-3.44%
BEAM - MGNX
46%
Loosely correlated
+1.25%
RGNX - MGNX
46%
Loosely correlated
-2.15%
SYRE - MGNX
46%
Loosely correlated
-1.64%
More

MRKR and

Correlation & Price change

A.I.dvisor tells us that MRKR and XNCR have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MRKR and XNCR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRKR
1D Price
Change %
MRKR100%
+4.79%
XNCR - MRKR
32%
Poorly correlated
-3.44%
RCKT - MRKR
32%
Poorly correlated
-2.58%
EYPT - MRKR
31%
Poorly correlated
-2.39%
MGNX - MRKR
31%
Poorly correlated
+1.68%
LRMR - MRKR
31%
Poorly correlated
-6.17%
More